United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
December 28, 2021
Date of Report (Date of earliest event reported)
Digital Health Acquisition Corp.
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 001-41015 | 86-2970927 | ||
|
(State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
|
980 N Federal Hwy #304 Boca Raton, FL |
33432 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (561) 672-7068
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||
| Units, each consisting of one share of Common Stock and one Redeemable Warrant | DHACU | The Nasdaq Global Market | ||
| Common Stock, par value $0.0001 per share | DHAC | The Nasdaq Global Market | ||
| Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 | DHACW | The Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 8.01 Other Events
On December 28, 2021, Digital Health Acquisition Corp. (the “Company”) issued a press release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K, announcing that the holders of the Company’s units (the “Units”) may elect to separately trade the shares of common stock, par value $0.0001 per share (the “Common Stock”) and warrants (“Warrants”) included in the Units commencing on or about December 30, 2021. Each Unit consists of one share of Common Stock and one Warrant. Each Warrant entitles its holder to purchase one share of Common Stock for $11.50 per share, subject to adjustment. Any Units not separated will continue to trade on the Nasdaq Global Market (“Nasdaq”) under the symbol “DHACU,” and the shares of Common Stock and Warrants will separately trade on Nasdaq under the symbols “DHAC” and “DHACW,” respectively. Holders of Units will need to have their brokers contact Continental Stock Transfer & Trust Company, LLC, the Company’s transfer agent, in order to separate the Units into shares of Common Stock and Warrants.
Item 9.01. Financial Statements and Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press Release, dated December 30, 2021 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: December 28, 2021 | ||
| DIGITAL HEALTH ACQUISITION CORP. | ||
| By: | /s/ Scott Wolf | |
| Name: | Scott Wolf | |
| Title: | Chief Executive Officer and Chairman | |
Exhibit 99.1
Digital Health Acquisition Corp. Announces the Separate Trading of its Shares of Common Stock and Warrants, Commencing December 30, 2021
New York, New York, December 28, 2021 -- Digital Health Acquisition Corp. (the "Company") announced today that, commencing on or about December 30, 2021 holders of the units sold in the Company’s initial public offering completed on November 8, 2021, may elect to separately trade the shares of common stock and warrants in the units on The Nasdaq Global Market (“Nasdaq”).
The shares of common stock and warrants that are separated will trade on Nasdaq under the symbols “DHAC” and “DHACW,” respectively. Those units not separated will continue to trade on Nasdaq under the symbol “DHACU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, LLC, the Company’s transfer agent, in order to separate the units into shares of common stock and warrants.
The units were initially offered by the Company in an underwritten offering. A.G.P./Alliance Global Partners acted as the sole book-running manager. A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the "SEC") on November 3, 2021. The offering was made only by means of a prospectus, copies of which may be obtained by contacting A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@allianceg.com or by visiting EDGAR on the SEC’s website at www.sec.gov.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Digital Health Acquisition Corp.
Digital Health Acquisition Corp is a blank check company sponsored by Digital Health Sponsor LLC, a Delaware limited liability company, whose business purpose is to effect a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on established, technology focused businesses positioned in the healthcare industry that have an aggregate enterprise value of approximately $175 million to $500 million and would benefit from access to public markets and the operational and strategic expertise of our management team and board of directors.
Forward Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the Company’s search for an initial business combination, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
Contacts:
for Investors:
Investor Relations
Digital Health Acquisition Corp.
info@digitalhealthacquisition.com
561-672-7068